NNovo Nordisk Read More Novo Nordisk: Zenagamtide and Etavopivat Shine, but the Market Only Sees CagriSema2026-06-11 Novo Nordisk’s shares continue to trade under a dark cloud, down roughly 46% over the past twelve months…